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Abstract 
 
The literature reveals that current nephrology practice in obtaining 
informed consent to dialysis falls short of ethical and legal requirements. 
Failure to meet these requirements represents a significant challenge, 
especially where the benefits and risks of dialysis have shifted 
significantly with the growing number of older, comorbid patients. The 
importance of informed consent for dialysis is heightened by several 
concerns including 1) the proportion of predialysis and dialysis patients 
who lack capacity in decision making and 2) whether older, co-morbid 
and frail patients understand their poor prognosis and the full 
implications to their independence and functional status of being on 
dialysis. This article outlines the ethical and legal requirements for a 
valid informed consent to dialysis: 1) that the patient was competent, 2) 
the consent was made voluntarily and 3) that the patient was given 
sufficient information in an understandable manner to make their 
decision. It then considers the application of these requirements into 
practice, across different countries. In the process of informed consent, 
the law requires a discussion by the physician of the material risks 
associated with dialysis and alternative options. We argue that legally 
and ethically this discussion should include both the anticipated 
trajectory of the illness and the effect on the life of the patient with 
particular regard to the outcomes most important to the individual. In 
addition, a discussion should occur about the option of a conservative, 
non-dialysis pathway. These requirements ensure that the ethical 
principle of respect for patient autonomy is honoured in the context of 
dialysis. Nephrologists need to be open to, comfortable with and skilful in 
communicating this information. From these clear, open, ethically and 
legally valid consent discussions a significant dividend will hopefully 
flow for patients, families and nephrologists alike. 
                                                     
 
 
Introduction 
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               In the modern era there has been a significant shift in the 
demographics of patients with end stage kidney (ESKD), with an increase 
in older and frailer patients who have multiple co-morbid conditions. This 
change has highlighted the imperative of carefully balancing the benefits 
and risks of dialysis treatment. This balance has medical, ethical and legal 
dimensions. Nephrologists, like all physicians, are well aware of the need 
for and importance of informed consent. There is, however, a major 
disconnect between that awareness and the reality of adherence to the 
requirements for informed consent for dialysis. (See Table 1 and Figure 
1). There are many possible causes for these deficits in practice, including 
an inadequate understanding of the legal requirements of informed 
consent; inadequate training or modelling of these conversations; a 
perception that prognostic data is insufficiently robust to make clear 
recommendations or, if countenanced, a reluctance to disclose such 
information; a belief that nephrologists have an ethical and/or legal 
obligation to offer dialysis to all patients and that failure to do so exposes 
clinicians to possible litigation; and a level of discomfort in having these 
conversations. Each of these challenges needs to be addressed. None are 
insuperable.  
 
               In this paper, we outline the legal requirements for a valid 
informed consent to dialysis at common law. Common law jurisdictions 
are those which are derived from English judge-made law including 
England and Wales, Northern Ireland, Eire, Australia, New Zealand, 
Canada and the United States. While there are jurisdictional differences, 
the basic legal elements of consent are shared across these countries.  
 
              Understanding the nature and content of informed consent to 
dialysis is important medically, ethically and legally. This process is 
especially important in light of: 
 
(i) the rapid growth in the number of older patients 
commencing dialysis (1), 
(ii) questions surrounding the capacity of patients with   
ESKD (2),  
(iii) literature comparing the survivorship of older, frailer more 
comorbid dialysis patients with those on a conservative, 
non-dialytic pathway (3)   
(iv) concerns expressed about the levels of information 
currently given to patients by nephrologists in the process 
of consent (4,5) and, as a result, 
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(v) uncertainty that patients understand the likely trajectory of 
their illness and the full implications of dialysis on their 
life, independence and functional status.  
 
               
Elements of consent 
 
                  The basic elements of a legally valid informed consent are: 
 
1. The patient must have the decision-making capacity to consent to 
the treatment.  
2. The consent should be an informed one with information given in 
an understandable manner.  
3. The consent should be made freely and voluntarily.  
4. The consent must cover the treatment given.  
           
           If any one of the elements is absent, the consent is legally invalid.   
An exception to this process is where a competent patient waives this 
right and hands over the process of decision making to another person, 
usually their family (6). The literature reveals a significant disconnect 
between these legal requirements and current nephrology practice (See 
Table 1). Ethicists have added further elements to the process of informed 
consent including the importance of a physician recommendation, a 
decision in favour of a clinical plan and authorization of that chosen plan 
in the signing of a consent form (7).   
           
Capacity 
 
An 84 year old man has ESKD secondary to hypertensive nephrosclerosis. During 
discussions about dialysis, it becomes obvious that the patient has significant short 
term memory loss and is struggling to manage at home.  
 
              The law presumes that an adult patient has the capacity to 
consent to medical treatment (8). That presumption, however, is open to 
challenge. If there are concerns it is prudent to organise a formal 
assessment of capacity. That prudence is especially important in view of 
the contemporary demographic profile of dialysis patients where, in 
developed nations, the age cohort of dialysis patients that has the greatest 
prevalence is the 65-84 year age group.  
 
              Decision-making capacity has three elements: understanding the 
information provided, retaining that information and reasoning to reach a 
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final decision (9). Capacity should be assessed in relation to the specific 
decision being made at that time.          
 
            There are two common clinical situations where difficulties with 
capacity may occur. The first is the patient with the uremic symptoms of 
drowsiness or confusion. The second is the patient with dementia. It is 
important to note that these conditions per se do not mean that the patient 
lacks capacity to make an informed consent. The issue is whether the 
patient understands, retains and reasons with sufficient capacity at the 
time the consent process occurs. 
Voluntariness 
 
A 72 year old man has polycystic kidney disease. He has had two renal transplants. 
The second is failing. He informs his family that, after considerable thought, he has 
chosen not go back onto dialysis. His nephrologist says to the patient - “I don’t think 
that is the right decision; in my view you really do not have a choice and you should 
go back onto dialysis.” One daughter repeatedly says to her father - “You must start. 
Mum has gone. We can’t lose you too. I couldn’t bear it if you went.” The patient 
consents to recommencing dialysis. 
 
              The law states that, for a medical consent to be valid, it should 
be made voluntarily and without undue influence (10). Distinguishing 
clinician recommendation and family opinion from undue influence can 
be difficult. In the English case of Re T (Adult : Refusal of Treatment) 
(11), the court emphasised that patients, by definition, are vulnerable due 
to their illness, and rely on the support of family and carers. The key 
difference between valid support and undue influence is the undermining 
of the independence of the patient (11). Lord Donaldson posited the test 
of undue influence as:  
 
Does the patient really mean what he says or is he merely saying it for a quiet life, to 
satisfy someone else or because the advice and persuasion to which he has been 
subjected is such that he can no longer think and decide for himself ? In other words 
“Is it a decision expressed in form only, not in reality ?” (11) 
 
            Variations on the scenario above are relatively familiar. 
Inevitably, family members will have and express an opinion on dialysis. 
If the patient above commences dialysis the question is not simply 
whether he was influenced but whether his will was overborne. In the 
above scenario, the nephrologist is incorrect, in both fact and law. The 
patient does have the choice of conservative kidney management and 
common law states that a competent adult has the right to refuse 
treatment (12).   
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Level of information required 
 
A 74 year old man has ESKD secondary to hypertensive nephrosclerosis. His 
nephrologist says to him “we will need to prepare you for dialysis.” He is told he will 
be referred to a vascular surgeon who will arrange vascular access and that his 
dialysis will occur three times per week. 
 
              The common law states that to exercise the right to determine 
what shall be done with his or her own body, a patient needs to be 
adequately informed by the clinician (13).  
 
          Broadly speaking, common law approaches this issue in two ways: 
 
1. The law of battery states that if a patient has a medical or surgical 
intervention without that person’s consent then the clinician has 
committed a wrong to that person. The information required to ensure 
consent is advice as to the nature and effects of the intervention (13).  
  
2. The law of negligence. As physicians, nephrologists owe their patients 
a duty of care. The standard of care is what a nephrologist would 
reasonably be expected to do in the examination, diagnosis and 
treatment of their patients. The latter includes the doctrine of informed 
consent. This doctrine requires that “the voluntary agreement by an 
individual to a proposed procedure, given after appropriate and 
reliable information about the procedure, including the potential risks 
and benefits has been conveyed to the individual.” (14) This doctrine 
is recognised in common law jurisdictions.  
             
             What level of information is required to be given by a 
nephrologist? In the context of dialysis it is 1) the nature of dialysis, 2) 
relative risks associated with dialysis and 3) alternatives to dialysis. In 
many jurisdictions, while courts may refer to the accepted practice of a 
body of nephrologists, the court is the ultimate judge as to whether that 
practice meets their standard of care (13). So it is not sufficient for a 
nephrologist to simply rely on common practice (“we don’t usually go 
into too much detail”) regarding consent to dialysis.  
 
           In the U.S. case of Canterbury v Spence, the court held that a 
physician should explain to a patient all the material risks of the treatment 
that a reasonable person in the position of the patient would be likely to 
attach significance (15). Since that case many courts in the US have 
followed the reasonable patient standard (16). In Canada, the Supreme 
Court in Reibl v Hughes agreed with this reasoning (17). In Australia, the 
High Court in Rogers v Whitaker (13) held that when physicians discuss 
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the relative risks associated with treatment they have “a duty to warn a 
patient of a material risk inherent in the proposed treatment; a risk is 
material if, in the circumstances of the particular case, a reasonable 
person in the patient’s position, if warned of the risk, would be likely to 
attach significance to it or if the medical practitioner is or should 
reasonably be aware that the particular patient, if warned of the risk, 
would be likely to attach significance to it.” (13) The Supreme Court of 
the United Kingdom in Montgomery (18) endorsed the Rogers v Whitaker 
test of what constitutes a material risk. In Eire, the Supreme Court of 
Ireland has, in more recent cases, favoured a move towards the 
reasonable patient standard (19). In New Zealand, the requirement to gain 
informed consent is codified : every patient must be provided with the 
information that a reasonable patient, in the patient’s circumstances, 
would expect to receive (20).  
 
The material risks associated with dialysis 
 
          Nephrologists have a duty to warn the patient of any material risk 
inherent in the process of dialysis. This might include the nature of 
ESKD, the role and nature of dialysis, the need for a dialysis routine and 
regular monitoring, changes in lifestyle and schedule, changes in diet, the 
known symptom burden of dialysis patients and the general 
complications of dialysis including post -dialysis fatigue, intra-dialytic 
hypotension, headaches, cramping, sepsis and issues of vascular access. 
The law requires a discussion that includes both general information and 
how this information relates to the individual patient in their 
circumstances.  
 
          It can be argued that the entire cohort of patients with ESKD might 
attach significance to a discussion about further material risks when they 
consider their individual situation, seeking to balance the inevitable 
imposition of dialysis upon their former life against their expected 
survival and likely quality of life. This is particularly relevant for patients 
who have characteristics associated with a poor prognosis on dialysis, 
including frail patients, many older patients, patients with significant 
comorbidities, chronic malnutrition and for whom the nephrologist 
estimates a limited prognosis (21). For these patients nephrologists might 
conclude that dialysis is likely to cause more harm than good. If the 
nephrologist reaches this conclusion with regard to a particular patient, 
ethicists would argue that the nephrologist is obliged to inform the patient 
and recommend against dialysis (7).   
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            In terms of the content of the information given, there are two 
areas of information that are particularly important: the anticipated 
trajectory of the disease and the impact of dialysis on the life of the 
patient. Both aspects should be discussed with an emphasis on the 
outcomes most important to the patient recognising that there are 
limitations in the currently available tools measuring both.  
 
(a) Trajectory 
 
Several years ago I asked…a capable and thoughtful nephrologist, “What is the most 
serious ethical problem in clinical nephrology?” Without hesitation she said, “our 
failure to inform patients with end stage renal disease of their [statistical] 
prognosis.”(4)  
 
Prognostic information is the single most important piece of information that patients 
need to make informed choices. (22) 
 
             For an individual patient, accurate prognostication of a patient’s 
life expectancy is challenging. Invariably, it involves a complex 
combination of objective measures and clinical intuition (23). Therein lies 
a challenge for physicians in communicating both clinical prognosis and 
uncertainty. Doing both is entirely appropriate. Indeed, Michel and Moss 
saw clear advantage of this combination for patients with ESKD. They 
stated “[i]n fact, it is in situations of clinical uncertainty that patients most 
want to introduce their extramedical values to assist in the decision-
making process; thus candor about uncertainty of prognosis may 
encourage shared decision making.” (5) When dialysis is being 
considered, prognostic information may be presented to the patient in 
various ways. The first is annual mortality data, specifically in age-
specific cohorts. Another is to compare the prognosis of patients with 
ESKD who pursue dialysis versus conservative management. Criteria 
found to be statistically associated with poor prognosis in dialysis patients 
have been listed above. In terms of conservative management, in one 
study, patients of average age 82 with ESKD who chose conservative 
management survived a median of 16 months and about one-third 
survived 12 months past a time when dialysis might otherwise have been 
indicated (eGFR below 10 mls/min) (24). While prognostic instruments 
may not be sufficiently sensitive or specific to inform an individual 
patient of their exact prognosis, they are informative at identifying high 
risk patients (25).  
 
(b) The impact on the life of the patient  
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A discussion about quality of life alone, as captured by current 
instruments, cannot capture the full implication of commencing 
dialysis on a patient and their family (25). Those impacts include 
limitations on their independence, time spent in the hospital or 
dialysis centre either on dialysis or with the complications of 
treatment, interference with usual daily activities including 
pastimes, changes in diet, the distance and time of travel to 
dialysis units, especially in rural and remote areas, problems 
with mobilising if frail and the ubiquity of post-dialysis fatigue 
and other symptoms. Patients approaching ESKD are often 
willing to trade months of life expectancy to reduce the burdens 
and restrictions on travel and independence imposed by dialysis 
(26). A summary of the material risks to be discussed in the 
process of informed consent for dialysis is provided in Table 2. 
 
Alternative treatment options 
 
            A patient with ESKD has three treatment options: dialysis, a 
conservative, non-dialysis pathway or renal transplantation. The legal 
obligation of a physician to explain to a patient other approaches to 
treatment was recognised in the Canadian case Haughian et al v Paine 
(27) and in Australia by Justice Kirby in Rosenberg v Percival (28). To 
Kirby, the failure to inform the patient of available alternatives means 
that “[a]ny choice by the patient…is meaningless.” (28) 
  
             A discussion about alternative options should be specific to the 
individual patient. For some patients this should include providing a clear 
explanation of the concept and content of conservative kidney 
management. It is important that the patient and family understand that 
conservative care is not medical abandonment and that the nephrologist 
will continue to review the patient. Ideally, conservative management 
should be a combination of excellent renal and palliative medicine (29). 
Over time, it is hoped a synthesis of these disciplines – kidney supportive 
care - will be a standard part of the practice of all nephrologists.  
 
Issues of communication 
 
              Nephrologists should be bilingual: they should speak the plain 
language of their patients and the technical language of their discipline. In 
terms of providing information and advice it is critically important that 
the nephrologist uses language that is clear and understandable to the 
patient.               
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           The second issue is the nature of the nephrologist-patient 
relationship. As with all health professionals, this is not a relationship of 
equals. There is an intrinsic vulnerability in being a patient, both 
physically and in terms of knowledge. For patients, the relationship with 
the nephrologist is one based on trust. In terms of informed consent, this 
places a responsibility on the doctor to be careful in acting upon that 
implied trust. As Beran stated “[t]he doctor must ensure that the 
relationship is not used as a ‘blunt instrument’ to achieve a desired 
outcome but rather should empower patients to decide their fate.” (30) 
 
              Overarching this discussion of communication is the importance 
of giving patients time to consider carefully their options, to talk to their 
family and, where necessary, have further discussions with their 
nephrologist. Importantly, as Miller stated in the context of information 
giving to patients with ESKD and dialysis : “To know what the patient 
would like to know, we need simply to ask, but having done so, we must 
then be silent and listen.” (4) (See Table 3). Finally, it is important to 
acknowledge that the provision of information to patients in a pre-dialysis 
setting may come from many sources including senior renal nurses and 
social workers. Nevertheless, the law holds the physician overseeing 
dialysis as ultimately responsible to ensure that the patient has made a 
valid, informed consent to treatment.  
 
           In the clinical scenario described at the beginning of this section, 
the information provided to the patient was procedural, not contextual. It 
did not contain any information on the benefits and risks involved in 
having dialysis, any explanation of prognosis or any discussion about 
quality of life. There was no discussion of the possibility of a 
conservative kidney management pathway. Finally, the patient was not 
informed that they had the right to refuse treatment at any time. The 
process of informed consent described in that case fell short of the 
standard we are espousing in this paper. 
 
Cultural and religious perspectives 
 
            Informed consent to medical treatment is founded on the principle 
of autonomy. Such a principle is regarded in diverse ways across cultures 
and religious faiths. For some, autonomy is paramount; for others it may 
be a foreign world view (31) whereby the cultural imperative may require 
that important decisions are made by the head of the family or 
collectively within families or close knit groups. This process may 
include the belief within families that difficult news will result in their 
loved one losing hope; the primacy of filial obligations favouring the 
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commencement of, or rejecting the withdrawal from, dialysis; the belief 
that forgoing dialysis constitutes abandonment, an immoral act or 
euthanasia; and, finally, a cultural prohibition against mentioning to the 
patient the trajectory of the illness, prognosis or death and dying. 
Recognition of these cultural and religious dimensions by nephrologists is 
important in all aspects of decision making including the process of 
informed consent (32).  
 
Role of guidelines and codes of ethics 
 
        In their deliberations, courts view professional guidelines and 
protocols seriously. While they may not be necessarily authoritative in 
those deliberations, courts find these sources of professional 
recommendations and practice extremely helpful and, indeed, may find 
that they inform the content of the duty of care. The main guidelines in 
Nephrology on informed consent are set out in Table 5. 
 
The right to refuse dialysis 
 
            A competent adult may refuse medical treatment including 
dialysis, even if that treatment is needed to stay alive (12). It does not 
matter whether the patient’s reasons for taking this decision are “rational, 
irrational, unknown or even non-existent.” (11)  
 
Emergency dialysis 
 
           An exception to the legal imperative of obtaining consent is a 
medical emergency (33). Dialysis may be initiated in the context of an 
acute illness and rapid or unexpected loss of kidney function. Once the 
emergency has resolved an informed consent process should commence 
for future dialysis management. The exception to this approach is where 
the patient, when competent, has expressly stated that he or she does not 
wish to commence dialysis even and including in the context of an 
emergency.   
 
Deciding for the incompetent patient 
 
            The law states that if a patient is incompetent then the physician 
should examine any advance care plan made by the patient when 
competent and discuss with a designated surrogate decision maker. If the 
patient has not expressed their wishes or nominated a surrogate decision 
maker, the physician should approach whoever is the medical surrogate 
decision maker under the provisions of the law in the relevant 
12 
 
jurisdiction. This decision-making process should be based on what the 
person would have chosen if competent in combination with the medical 
recommendations. In the context of dementia, that recommendation 
should be based on the anticipated clinical trajectory of dementia, the 
troubling sequelae to the initiation of dialysis in nursing home residents 
including patients with dementia (34) and the Renal Physicians 
Association guidelines which recommended that “It is appropriate to 
forgo dialysis for patients with…irreversible, profound neurological 
impairment…” (21)  
 
 
 
 
Resolution of conflict 
 
              In the process of decision making, there may be conflict between 
the family and the nephrologist. Legally and ethically, physicians are 
under no obligation to provide treatment, including dialysis, where the 
physician conscientiously feels that this treatment is inappropriate or 
excessively burdensome to the patient. Strategies here include 
recommending a cooling off period for the family to consider the matter 
further, seeking the second opinion of another nephrologist and, most 
definitively, bringing the case to a court to resolve the issue.  
 
Conclusions  
 
               There are two common themes to the challenges to 
nephrologists in informed consent to dialysis: awareness and 
preparedness. Awareness necessitates knowledge and understanding of 
the law of consent, summarized in Table 2. Preparedness is the 
willingness of nephrologists to expand consent conversations beyond the 
mechanical aspects of dialysis to include topics such as prognosis, quality 
of life, the aspects of life that matter most to the patient and the option of 
conservative kidney management. An important dividend that flows from 
such an open and transparent approach is that any other discussion about 
future planning or crisis management becomes easier to initiate and 
conduct. A consent discussion is foundational. All later discussions will 
be far more comfortable in its shadow.  
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Table 1 
 
A disconnect between the legal requirements and current practice 
           
1. The vast majority of nephrology patients want to be given as much 
information as possible, good or bad, including prognosis (35).  
 
2. Patients expect that this information should be given without needing to 
prompt the nephrologist (35).  
 
3.  In a study of maintenance dialysis patients, nearly 70 % reported that the risks 
and burdens of dialysis had never been mentioned prior to commencing 
dialysis and only 1 % of patients recalled the option of a conservative pathway 
being discussed (36).  
 
4. In a study of dialysis patients in Boston, none of the patients reported having a 
discussion about prognosis with their nephrologists. In that study, 
nephrologists reported that, for 60 % of patients, they would not provide any 
estimate of prognosis even if the patient insisted on knowing (37). 
 
5. In a study of dialysis patients, they reported that, in their pre-dialysis 
discussions, there was no mention of prognosis or how dialysis may affect 
their lives. The nephrologists, in turn, conceded that they did not discuss 
prognosis unless prompted. Many patients felt a sense of resignation to 
dialysis, especially when the nephrologists framed the decision as choosing 
between life and death (38).  
 
6. In a series of open-ended interviews and participant observation studies of 43 
dialysis patients, only two patients perceived that the initiation of dialysis was 
their decision. The investigators found that “[m]ost insisted ‘there was no 
decision – it just happens.’ ” The investigators observed that nephrologists 
framed the need for dialysis in terms of “when you will need to start dialysis 
not if.” (39) 
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7. Among older hemodialysis patients interviewed to determine whether 
informed consent had been obtained, most of the patients lacked sufficient 
understanding of their clinical circumstances. (40)  
 
8. In national surveys of US adult nephrology fellows conducted in 2014 and 
2015, nearly one in five stated they felt obligated to offer dialysis to every 
patient regardless of benefit (41).  
 
9. In a Canadian study, 61 % of patients regretted commencing dialysis (42).          
      When this cohort was asked why dialysis had been chosen over conservative     
      management 52 % reported that it was their physician’s wish and 14 %    
      because it was their family’s wish. 
 
 
Figure 1: The elements of a legally valid consent for dialysis 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have capacity to make an informed consent? 
The nephrologist should check if the patient understands and retains information and employs 
reasoning 
CAPACITY 
Was the decision made freely 
and voluntarily? 
If the patient is incompetent,  
consent is required from a 
surrogate decision-maker or may 
be fulfilled if a preference was 
stated by the patient in an 
advance care plan. 
Decision must be made with 
sufficient information as per 
individual patient decision 
 
Seek Assessment 
 
If there is any concern, the 
nephrologist should confirm 
with a formal assessment or 
referral. 
 
VOLUNTARY 
SUFFICIENT INFORMATION 
Yes 
Not Sure No 
No Yes 
Does the patient have capacity to 
make an informed consent? No 
Yes 
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Table 2 
 
 
Material risks of dialysis 
 
As part of the informed consent process and underpinned by the principle of shared 
decision making, the following material risks should be discussed: 
 
1. General complications of dialysis including vascular access, sepsis, 
intradialytic hypertension and hypotension, fluid overload and post-dialysis 
fatigue 
 
2. Prognosis as assessed by available prognostic tools. 
 
3. Anticipated effect on the life of the patient, family and carers. 
 
 
Table 3 
 
Important aspects of communication in the process of informed 
consent 
 
• The importance of shared decision making as recommended by the Renal 
Physicians Association. (21) 
• Inviting the family to be part of the discussion.  
Consent invalid 
 
Was sufficient information given to the patient in an 
understandable manner ? 
 
• The role of dialysis 
• The logistics of ongoing dialysis treatment 
• The benefits and risks of dialysis including the likely trajectory 
of the disease and the effect on the life of the patient.  
• Any risks material to the individual patient 
• An explanation of the option and role of conservative care. 
Legally/ Valid Informed Consent 
Foundational Principles of Informed Consent 
• There is no legal or ethical requirement on a nephrologist to offer dialysis to all patients. 
• The initiation of dialysis on a competent adult patient requires their consent. 
• The patient may waive this right and give his or her decision-making power to another person (s). 
•  A competent patient has the right to refuse dialysis. 
 
Yes 
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• Quiet environment 
• Clear understandable language - avoid technical language. 
• Nephrologist-patient relationship – recognise patient vulnerability physically 
and in terms of knowledge. 
• Allowing patient and family an opportunity to clarify and question information 
• Information may come from multiple sources – Nephrologist, Renal Nurses, 
Renal Social Worker. 
• Give patients and families time to consider decisions. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 
 
Recognition of and guidelines for informed consent in Nephrology 
 
USA 
 
        Renal Physicians Association Guidelines (21).  
 
           CMS Conditions for Coverage states that patients in renal units have a basic 
right to informed consent that is entrusted to the medical director of the dialysis 
facility (43).  
             
             The American Society of Nephrology (ASN) in conjunction with the 
American Board of Internal Medicine Foundation’s “Choosing Wisely” campaign, 
recommends that nephrologists “not initiate chronic dialysis without ensuring a shared 
decision-making process between patients, their families, and their physician.” (44) 
            
               The American Medical Association (45)  
 
UK 
 
                Department of Health guidelines on informed consent (46).  
 
Canada  
 
                One of the “key and enabling” competencies of trainees in Nephrology is 
the ability to obtain an informed consent (47). 
17 
 
 
Australasia 
 
                 In Australasia, the Caring for Australasians with Renal Impairment (CARI) 
guidelines for Nephrology practice emphasises the importance of an informed consent 
to dialysis (48).  
 
                 In Australia, the National Health and Medical Research Council guidelines 
on the provision of information to patients (49).  
 
                 The Australian and New Zealand Society of Nephrology (ANZSN) Renal 
Supportive Care guidelines 2013 has chapters on prognosis, the law and the ethics of 
dialysis (50). 
 
                  New Zealand has a statutory regime governing informed consent (20). 
 
Republic of Ireland 
 
                  Irish Medical Council guidelines to physicians on informed consent (51).  
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